Opportunities for personalizing colorectal cancer care: an analysis of SEER-medicare data.

Rivers, Zachary T; Parsons, Helen M; Jacobson, Pamala A; Kuntz, Karen M; Farley, Joel F; Stenehjem, David J

Rivers, Zachary T; Parsons, Helen M; Jacobson, Pamala A; Kuntz, Karen M; Farley, Joel F; Stenehjem, David J.

Afiliação

Rivers ZT; Department of Pharmaceutical Care and Health Systems, University of Minnesota College of Pharmacy, Minneapolis, MN, USA. zrivers@fredhutch.org.
Parsons HM; Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. zrivers@fredhutch.org.
Jacobson PA; Division of Health Policy and Management, University of Minnesota School of Public Health, Minneapolis, MN, USA.
Kuntz KM; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.
Farley JF; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.
Stenehjem DJ; Department of Experimental and Clinical Pharmacology, University of Minnesota College of Pharmacy, Minneapolis, MN, USA.

Pharmacogenomics J ; 22(3): 198-209, 2022 05.

Article em En | MEDLINE | ID: mdl-35361994

Assuntos

Neoplasias Colorretais; Medicare; Idoso; Estudos de Coortes; Neoplasias Colorretais/tratamento farmacológico; Neoplasias Colorretais/genética; Etnicidade; Humanos; Farmacogenética; Testes Farmacogenômicos; Estados Unidos/epidemiologia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Medicare Tipo de estudo: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans País/Região como assunto: America do norte Idioma: En Revista: Pharmacogenomics J Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google